Pax5/BSAP Antibody (1H9) Summary
| Immunogen |
The immunogen for this antibody is Pax5, BSAP (1H9).
|
| Isotype |
IgG2a Kappa
|
| Clonality |
Monoclonal
|
| Host |
Rat
|
| Gene |
PAX5
|
| Purity |
Protein A or G purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
This 1H9 antibody has been tested by western blot analysis. This can be used at less than or equal to 5ug/ml. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. This 1H9 antibody has also been reported for use in immunoprecipitation and immunohistology staining of frozen tissue sections.
|
Packaging, Storage & Formulations
| Storage |
Store at 4C. Do not freeze.
|
| Buffer |
Aqueous, may contain carrier protein/stabilizer.
|
| Preservative |
0.09% Sodium Azide
|
| Concentration |
0.5 mg/ml
|
| Purity |
Protein A or G purified
|
Alternate Names for Pax5/BSAP Antibody (1H9)
- B cell specific activator protein
- B-cell-specific transcription factor
- BSAP
- BSAPB-cell lineage specific activator
- paired box 5
- paired box gene 5 (B-cell lineage specific activator protein)
- paired box gene 5 (B-cell lineage specific activator)
- paired box homeotic gene 5
- paired box protein Pax-5
- Pax5
- transcription factor PAX 5
Background
The monoclonal antibody 1H9 recognizes both mouse and human Pax5. Pax5, also known as BSAP (B cell specific activator protein), is a member of the paired box (pax) family of transcription factors. Pax5 is the only member of the pax family of transcription factors that is expressed in hematopoietic cells. During embryogenesis, Pax5 is transiently expressed in the brain of mice and in the mesencephalon and spinal cord of humans. Its expression is upregulated early in B cell development at the time of B cell commitment and is maintained throughout most subsequent stages. Suppression of Pax5 is essential for expression of Blimp-1 and the terminal differentiation of plasma cells. In the spleen, expression of Pax5 is higher in marginal zone B cells (B220+ CD21high CD23low) than in other B cells, especially the transition 1 stage (B220+ CD21- CD23-). In addition to its role in B cell development, Pax5 also affects VHDJH heavy chain recombination as well as influencing the expression of many other B and non-B cell related proteins. Pax5 expression is correlated with many neoplasms. In diffuse large B cell lymphomas (DLBCL) and non-Hodgkin lymphomas Pax5 is often mutatedwhile in B-cell ALL, expression levels are high. Additionally, translocation with elastin, IGH, ETV6, FOXP1, and EVI3 have been identified.